2arq: Difference between revisions

New page: left|200px<br /> <applet load="2arq" size="450" color="white" frame="true" align="right" spinBox="true" caption="2arq, resolution 1.85Å" /> '''Human plasminogen a...
 
No edit summary
Line 1: Line 1:
[[Image:2arq.gif|left|200px]]<br />
[[Image:2arq.gif|left|200px]]<br /><applet load="2arq" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="2arq" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="2arq, resolution 1.85&Aring;" />
caption="2arq, resolution 1.85&Aring;" />
'''Human plasminogen activator inhibitor-2.[loop (66-98) deletion mutant] complexed with peptide n-acetyl-teaaagdggvmtgr-oh'''<br />
'''Human plasminogen activator inhibitor-2.[loop (66-98) deletion mutant] complexed with peptide n-acetyl-teaaagdggvmtgr-oh'''<br />


==Overview==
==Overview==
The serine protease inhibitor (serpin) superfamily is involved in a wide, range of cellular processes including fibrinolysis, angiogenesis, apoptosis, inflammation, metastasis and viral pathogenesis. Here, we, investigate the unique mousetrap inhibition mechanism of serpins through, saturation mutagenesis of the P8 residue for a typical family member, plasminogen activator inhibitor-2 (PAI-2). A number of studies have, proposed an important role for the P8 residue in the efficient insertion, and stabilisation of the cleaved reactive centre loop (RCL), which is a, key event in the serpin inhibitory mechanism. The importance of this, residue for inhibition of the PAI-2 protease target urinary plasminogen, activator (urokinase, uPA) is confirmed, although a high degree of, tolerance to P8 substitution is observed. Out of 19 possible PAI-2 P8, mutants, 16 display inhibitory activities within an order of magnitude of, the wild-type P8 Thr species. Crystal structures of complexes between, PAI-2 and RCL-mimicking peptides with P8 Met or Asp mutations are, determined, and structural comparison with the wild-type complex, substantiates the ability of the S8 pocket to accommodate disparate, side-chains. These data indicate that the identity of the P8 residue is, not a determinant of efficient RCL insertion, and provide further evidence, for functional plasticity of key residues within enzyme structures. Poor, correlation of observed PAI-2 P8 mutant activities with a range of, physicochemical, evolutionary and thermodynamic predictive indices, highlights the practical limitations of existing approaches to predicting, the molecular phenotype of protein variants.
The serine protease inhibitor (serpin) superfamily is involved in a wide range of cellular processes including fibrinolysis, angiogenesis, apoptosis, inflammation, metastasis and viral pathogenesis. Here, we investigate the unique mousetrap inhibition mechanism of serpins through saturation mutagenesis of the P8 residue for a typical family member, plasminogen activator inhibitor-2 (PAI-2). A number of studies have proposed an important role for the P8 residue in the efficient insertion and stabilisation of the cleaved reactive centre loop (RCL), which is a key event in the serpin inhibitory mechanism. The importance of this residue for inhibition of the PAI-2 protease target urinary plasminogen activator (urokinase, uPA) is confirmed, although a high degree of tolerance to P8 substitution is observed. Out of 19 possible PAI-2 P8 mutants, 16 display inhibitory activities within an order of magnitude of the wild-type P8 Thr species. Crystal structures of complexes between PAI-2 and RCL-mimicking peptides with P8 Met or Asp mutations are determined, and structural comparison with the wild-type complex substantiates the ability of the S8 pocket to accommodate disparate side-chains. These data indicate that the identity of the P8 residue is not a determinant of efficient RCL insertion, and provide further evidence for functional plasticity of key residues within enzyme structures. Poor correlation of observed PAI-2 P8 mutant activities with a range of physicochemical, evolutionary and thermodynamic predictive indices highlights the practical limitations of existing approaches to predicting the molecular phenotype of protein variants.


==About this Structure==
==About this Structure==
2ARQ is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with ACE as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2ARQ OCA].  
2ARQ is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=ACE:'>ACE</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2ARQ OCA].  


==Reference==
==Reference==
Line 14: Line 13:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Curmi, P.M.]]
[[Category: Curmi, P M.]]
[[Category: Giusto, D.A.Di.]]
[[Category: Giusto, D A.Di.]]
[[Category: Harrop, S.J.]]
[[Category: Harrop, S J.]]
[[Category: Jankova, L.]]
[[Category: Jankova, L.]]
[[Category: King, G.C.]]
[[Category: King, G C.]]
[[Category: Sutherland, A.P.]]
[[Category: Sutherland, A P.]]
[[Category: ACE]]
[[Category: ACE]]
[[Category: peptide binding]]
[[Category: peptide binding]]
[[Category: serpin]]
[[Category: serpin]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:53:57 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:30:21 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA